(MedPage Today) -- The buprenorphine-naloxone combination product (Suboxone) in sublingual tablet form will soon be pulled from the U.S. market because its child-resistant packaging isn't effective enough. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment